Pesquisa | BVS Violência e Saúde

1.

Evaluation of tacrine hydrochloride (Cognex) in two parallel-group studies.

Gracon, S I.

Acta Neurol Scand Suppl ; 165: 114-22, 1996.

Artigo em Inglês | MEDLINE | ID: mdl-8740998

2.

Observations on the short-term 'natural history' of probable Alzheimer's disease in a controlled clinical trial.

Knopman, D; Gracon, S.

Neurology ; 44(2): 260-5, 1994 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-8309570

3.

The Clinician Interview-Based Impression (CIBI): a clinician's global change rating scale in Alzheimer's disease.

Knopman, D S; Knapp, M J; Gracon, S I; Davis, C S.

Neurology ; 44(12): 2315-21, 1994 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-7991118

4.

Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality, Tacrine Study Group.

Knopman, D; Schneider, L; Davis, K; Talwalker, S; Smith, F; Hoover, T; Gracon, S.

Neurology ; 47(1): 166-77, 1996 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-8710072

5.

Cardinal features of cognitive dysfunction in Alzheimer's disease: a factor-analytic study of the Alzheimer's Disease Assessment Scale.

Talwalker, S; Overall, J E; Srirama, M K; Gracon, S I.

J Geriatr Psychiatry Neurol ; 9(1): 39-46, 1996 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-8679062

6.

Safety and immunogenicity of a novel nanoemulsion mucosal adjuvant W805EC combined with approved seasonal influenza antigens.

Stanberry, L R; Simon, J K; Johnson, C; Robinson, P L; Morry, J; Flack, M R; Gracon, S; Myc, A; Hamouda, T; Baker, J R.

Vaccine ; 30(2): 307-16, 2012 Jan 05.

Artigo em Inglês | MEDLINE | ID: mdl-22079079

7.

Next generation tacrine.

Schwarz, R D; Davis, R E; Gracon, S; Hoover, T; Moos, W H; Pavia, M R.

Neurobiol Aging ; 12(2): 185-7, 1991.

Artigo em Inglês | MEDLINE | ID: mdl-2052133

8.

Long-term tacrine treatment effects.

Knopman, D; Schneider, L; Davis, K; Gracon, S; Smith, F.

Neurology ; 50(2): 567-8, 1998 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-9484404

9.

Amyloid and lipids in the pathology of Alzheimer disease.

Roher, A E; Kuo, Y M; Kokjohn, K M; Emmerling, M R; Gracon, S.

Amyloid ; 6(2): 136-45, 1999 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-10439121

10.

[Advantages in long-term treatment with Cognex in Alzheimer disease]. / Vorteile der Langzeitbehandlung mit Cognex bei der Alzheimer-Krankheit.

Gracon, S; Smith, F; Shokry, A.

Praxis (Bern 1994) ; 86(35): 1350-4, 1997 Aug 27.

Artigo em Alemão | MEDLINE | ID: mdl-9381027

11.

The use of survival analysis techniques in evaluating the effect of long-term tacrine (Cognex) treatment on nursing home placement and mortality in patients with Alzheimer's disease.

Smith, F; Talwalker, S; Gracon, S; Srirama, M.

J Biopharm Stat ; 6(4): 395-409, 1996 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-8969976

12.

Poxvirus infection in a colony of common marmosets (Callithrix jacchus).

Gough, A W; Barsoum, N J; Gracon, S I; Mitchell, L; Sturgess, J M.

Lab Anim Sci ; 32(1): 87-90, 1982 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-6281571

13.

An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease. The Tacrine 970-6 Study Group.

Foster, N L; Petersen, R C; Gracon, S I; Lewis, K.

Dementia ; 7(5): 260-6, 1996.

Artigo em Inglês | MEDLINE | ID: mdl-8872417

14.

Early human trials in the assessment of cognition activators.

Gamzu, E R; Birkhimer, L J; Hoover, T; Gracon, S T.

Pharmacopsychiatry ; 23 Suppl 2: 44-8, 1990 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-2186411

15.

A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.

Knapp, M J; Knopman, D S; Solomon, P R; Pendlebury, W W; Davis, C S; Gracon, S I.

JAMA ; 271(13): 985-91, 1994 Apr 06.

Artigo em Inglês | MEDLINE | ID: mdl-8139083

16.

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease.

Watkins, P B; Zimmerman, H J; Knapp, M J; Gracon, S I; Lewis, K W.

JAMA ; 271(13): 992-8, 1994 Apr 06.

Artigo em Inglês | MEDLINE | ID: mdl-8139084

17.

A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.

Farlow, M; Gracon, S I; Hershey, L A; Lewis, K W; Sadowsky, C H; Dolan-Ureno, J.

JAMA ; 268(18): 2523-9, 1992 Nov 11.

Artigo em Inglês | MEDLINE | ID: mdl-1404819

18.

Steady-state pharmacokinetics of tacrine in patients with Alzheimer's disease.

Cutler, N R; Sedman, A J; Prior, P; Underwood, B A; Selen, A; Balogh, L; Kinkel, A W; Gracon, S I; Gamzu, E R.

Psychopharmacol Bull ; 26(2): 231-4, 1990.

Artigo em Inglês | MEDLINE | ID: mdl-2236461

19.

Safety of tacrine: clinical trials, treatment IND, and postmarketing experience.

Gracon, S I; Knapp, M J; Berghoff, W G; Pierce, M; DeJong, R; Lobbestael, S J; Symons, J; Dombey, S L; Luscombe, F A; Kraemer, D.

Alzheimer Dis Assoc Disord ; 12(2): 93-101, 1998 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-9651138

20.

MRI as a biomarker of disease progression in a therapeutic trial of milameline for AD.

Jack, C R; Slomkowski, M; Gracon, S; Hoover, T M; Felmlee, J P; Stewart, K; Xu, Y; Shiung, M; O'Brien, P C; Cha, R; Knopman, D; Petersen, R C.

Neurology ; 60(2): 253-60, 2003 Jan 28.

Artigo em Inglês | MEDLINE | ID: mdl-12552040

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: